180 related articles for article (PubMed ID: 33995648)
1. KIF11 is upregulated in colorectal cancer and silencing of it impairs tumor growth and sensitizes colorectal cancer cells to oxaliplatin via p53/GSK3β signaling.
Zhou Y; Yang L; Xiong L; Wang K; Hou X; Li Q; Kong F; Liu X; He J
J Cancer; 2021; 12(12):3741-3753. PubMed ID: 33995648
[TBL] [Abstract][Full Text] [Related]
2. Micro1278 Leads to Tumor Growth Arrest, Enhanced Sensitivity to Oxaliplatin and Vitamin D and Inhibits Metastasis
Lin W; Zou H; Mo J; Jin C; Jiang H; Yu C; Jiang Z; Yang Y; He B; Wang K
Front Oncol; 2021; 11():637878. PubMed ID: 33791222
[TBL] [Abstract][Full Text] [Related]
3. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
[TBL] [Abstract][Full Text] [Related]
4. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637.
Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X
EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of Mir-135b Sensitizes Colorectal Cancer Cells to Oxaliplatin-Induced Apoptosis Through Increase of FOXO1.
Qin Y; Li L; Wang F; Zhou X; Liu Y; Yin Y; Qi X
Cell Physiol Biochem; 2018; 48(4):1628-1637. PubMed ID: 30071508
[TBL] [Abstract][Full Text] [Related]
6. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52.
Zhou Q; Hou Z; Zuo S; Zhou X; Feng Y; Sun Y; Yuan X
Cancer Sci; 2019 Apr; 110(4):1194-1207. PubMed ID: 30690837
[TBL] [Abstract][Full Text] [Related]
7. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z
Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977
[TBL] [Abstract][Full Text] [Related]
8. PPP2R1B abolishes colorectal cancer liver metastasis and sensitizes Oxaliplatin by inhibiting MAPK/ERK signaling pathway.
Liu W; Tang J; Gao W; Sun J; Liu G; Zhou J
Cancer Cell Int; 2024 Mar; 24(1):90. PubMed ID: 38429738
[TBL] [Abstract][Full Text] [Related]
9. KIF11 Is Required for Spheroid Formation by Oesophageal and Colorectal Cancer Cells.
Imai T; Oue N; Sentani K; Sakamoto N; Uraoka N; Egi H; Hinoi T; Ohdan H; Yoshida K; Yasui W
Anticancer Res; 2017 Jan; 37(1):47-55. PubMed ID: 28011472
[TBL] [Abstract][Full Text] [Related]
10. Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells.
Cherradi S; Garambois V; Marines J; Andrade AF; Fauvre A; Morand O; Fargal M; Mancouri F; Ayrolles-Torro A; Vezzo-Vié N; Jarlier M; Loussaint G; Huvelle S; Joubert N; Mazard T; Gongora C; Pourquier P; Boissière-Michot F; Rio MD
Cell Biosci; 2023 Apr; 13(1):72. PubMed ID: 37041570
[TBL] [Abstract][Full Text] [Related]
11. LINC00460-miR-149-5p/miR-150-5p-Mutant p53 Feedback Loop Promotes Oxaliplatin Resistance in Colorectal Cancer.
Meng X; Sun W; Yu J; Zhou Y; Gu Y; Han J; Zhou L; Jiang X; Wang C
Mol Ther Nucleic Acids; 2020 Dec; 22():1004-1015. PubMed ID: 33251049
[TBL] [Abstract][Full Text] [Related]
12. The SOX9-MMS22L Axis Promotes Oxaliplatin Resistance in Colorectal Cancer.
Liu Y; Wu H; Luo T; Luo Q; Meng Z; Shi Y; Li F; Liu M; Peng X; Liu J; Xu C; Tang W
Front Mol Biosci; 2021; 8():646542. PubMed ID: 34124145
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
[No Abstract] [Full Text] [Related]
14. KIF11 As a Potential Pan-Cancer Immunological Biomarker Encompassing the Disease Staging, Prognoses, Tumor Microenvironment, and Therapeutic Responses.
Guo X; Zhou L; Wu Y; Li J
Oxid Med Cell Longev; 2022; 2022():2764940. PubMed ID: 36742345
[TBL] [Abstract][Full Text] [Related]
15. HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway.
Liu W; Zhang Z; Zhang Y; Chen X; Guo S; Lei Y; Xu Y; Ji C; Bi Z; Wang K
Cancer Biol Ther; 2015; 16(4):511-7. PubMed ID: 25778491
[TBL] [Abstract][Full Text] [Related]
16. Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer.
Chen ZH; Qi JJ; Wu QN; Lu JH; Liu ZX; Wang Y; Hu PS; Li T; Lin JF; Wu XY; Miao L; Zeng ZL; Xie D; Ju HQ; Xu RH; Wang F
J Exp Clin Cancer Res; 2019 May; 38(1):196. PubMed ID: 31088567
[TBL] [Abstract][Full Text] [Related]
17. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
[TBL] [Abstract][Full Text] [Related]
18. KIF11 Functions as an Oncogene and Is Associated with Poor Outcomes from Breast Cancer.
Zhou J; Chen WR; Yang LC; Wang J; Sun JY; Zhang WW; He ZY; Wu SG
Cancer Res Treat; 2019 Jul; 51(3):1207-1221. PubMed ID: 30590004
[TBL] [Abstract][Full Text] [Related]
19. RNA-binding protein CELF1 enhances cell migration, invasion, and chemoresistance by targeting ETS2 in colorectal cancer.
Wang H; Huang R; Guo W; Qin X; Yang Z; Yuan Z; Wei Y; Mo C; Zeng Z; Luo J; Cai J; Wang H
Clin Sci (Lond); 2020 Jul; 134(14):1973-1990. PubMed ID: 32677671
[TBL] [Abstract][Full Text] [Related]
20. Annexin A3 depletion overcomes resistance to oxaliplatin in colorectal cancer via the MAPK signaling pathway.
Xu R; Yin J; Zhang Y; Zhang S
J Cell Biochem; 2019 Sep; 120(9):14585-14593. PubMed ID: 30998268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
